Scientific organizer:
 |
 |
 |
 |
PD Dr. med. Gregor Hörmann, PhD Laboratoriumsmediziner MLL Münchner Leukämielabor GmbH
Introduction.
Sergiy Klymenko (Ukraine)
Treatment of acute myeloid leukemia in patients suitable for intensive chemotherapy.
Olga Mishcheniuk (Ukraine)
AML. Patient journey. Response criteria. Monitoring.
Oksana Karnabeda (Ukraine)
An individual approach to the choice of ITK therapy.
Natalia Hlushko (Ukraine)
Modern approaches to the treatment of acute myeloid leukemia in patients not considered candidates for intensive therapy. Project of the Clinical Guidelines and Unified Clinical Protocol of primary and specialized medical care.
Tetyana Perekhrestenko (Ukraine)
Q&A
Introduction. Moderators
How to survive Babylonian confusion of languages in AML diagnostics in 2023.
Gregor Hörmann (Germany)
Q&A
AML treatment in 2023.
Arnold Ganser (Germany)
Q&A
Diagnostics and possibilities of innovative treatment of FLT3 positive AML in Ukraine.
Sergiy Klymenko (Ukraine)
Q&A
© 2024 - OPENlikar. All rights reserved.
